Nautilus Biotechnology Income Statement (2020-2026) | NAUT

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
6.38M8.24M9.89M9.66M8.86M9.57M9.59M10.88M11.91M12.00M12.47M12.93M12.44M12.29M12.82M11.54M10.39M9.61M9.57M9.71M
Selling, General & Administrative (Quarter)
4.32M6.32M6.92M6.36M6.62M6.25M6.72M7.18M7.10M7.08M7.54M8.68M8.35M6.81M7.16M7.31M6.70M5.87M5.85M6.42M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
10.70M14.57M16.82M16.02M15.47M15.82M16.30M18.06M19.02M19.07M20.00M21.61M20.79M19.10M19.98M18.84M17.10M15.47M15.42M16.12M
Operating Income (Quarter)
EBIT (Quarter)
Non-operating items
Non Operating Investment Income (Quarter)
Other Non Operating Income (Quarter)
-0.07M0.01M-0.13M-0.01M
Non Operating Income (Quarter)
-0.02M0.14M0.27M0.26M0.78M1.76M2.90M3.10M3.21M3.20M2.98M2.88M2.80M2.65M2.47M2.23M2.08M1.90M1.68M1.44M
Net income details
EBT (Quarter)
Profit After Tax (Quarter)
-10.72M-14.50M-16.68M-15.76M-14.69M-14.06M-13.41M-14.96M-15.81M-15.88M-17.02M-18.73M-18.01M-16.45M-17.59M-16.61M-15.03M-13.57M-13.78M-14.70M
Income from Continuing Operations (Quarter)
Consolidated Net Income (Quarter)
Income towards Parent Company (Quarter)
Net Income towards Common Stockholders (Quarter)
Additional items
EPS (Basic) (Quarter)
EPS (Diluted) (Quarter)
Shares Outstanding (Quarter)
55.07M124.11M84.46M124.42M124.49M124.65M124.59M124.59M124.60M124.93M124.92M125.14M125.32M125.45M125.43M126.14M126.20M126.31M126.26M126.63M
Shares Outstanding (Diluted) (Quarter)
55.07M124.11M84.46M124.42M124.49M124.65M124.59M124.59M124.60M124.93M124.92M125.14M125.32M125.45M125.43M126.14M126.20M126.31M126.26M126.63M
EBITDA (Quarter)
Interest Expenses (Quarter)
46.97M25.31M0.60M0.60M43.30M42.23M-2.68M1.20M49.80M48.18M-4.43M1.70M42.90M41.15M1.80M1.80M35.80M34.00M-5.37M27.04M